Preventing hyperthermia decreases brain damage following neonatal hypoxic-ischemic seizures.
Neonatal seizures are the most common manifestation of underlying cerebral dysfunction. Hypoxic-ischemic encephalopathy is the cause of seizures in 40-60% of newborns. Previous work from our laboratory demonstrates that seizures associated with a hypoxic-ischemic insult results in aggravation of neuronal cell death, specifically within the hippocampus. The latter occurs in the setting of spontaneously occurring hyperthermia of 1.5 degrees C. The purpose of this study was to determine whether preventing the onset of seizure induced hyperthermia would be neuroprotective. Three groups of 10-day old rat pups received unilateral hypoxic-ischemic insults for 30 min followed by KA-induced seizures. Hyperthermia was prevented by lowering the environmental temperature ("relative hypothermia") to 29 degrees C such that the seizuring rat pups were normothermic. In one group, the prevention of hyperthermia occurred immediately following hypoxia-ischemia, whereas in the other group it occurred at the onset of seizures. The third group of rat pups (controls) remained at their nesting temperature and therefore became hyperthermic during seizures. Early (3 days) and late (20 days) neuropathology was assessed. Rat pups in whom hyperthermia was prevented during seizures displayed a significant reduction in brain damage compared to controls (p<0.05). Assessment of hippocampal brain damage also showed a significant improvement in neuronal necrosis at 20 days of recovery compared to 3 days of recovery (p<0.05). The results indicate that preventing spontaneous hyperthermia in this model of hypoxic-ischemic seizures in the newborn is neuroprotective.
Yager
Jerome Y
JY
Department of Pediatrics, University of Saskatchewan, 103 Hospital Drive, Saskatoon, Saskatchewan, Canada S7N 0W8. yager55@telus.net
Armstrong
Edward A
EA
Jaharus
Cleo
C
Saucier
Deborah M
DM
Wirrell
Elaine C
EC
D000704:Analysis of Variance; D000818:Animals; D000831:Animals, Newborn; D001831:Body Temperature / Q000502:physiology; D004562:Electrocardiography / Q000379:methods; D004569:Electroencephalography / Q000187:drug effects; D005260:Female; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D006979:Hyperthermia, Induced; D000860:Hypoxia / Q000150:complications*; D002534:Hypoxia, Brain / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D007511:Ischemia / Q000150:complications*; D007608:Kainic Acid; D051381:Rats; D017208:Rats, Wistar; D012640:Seizures / Q000139:chemically induced / Q000150:complications; D013997:Time Factors
D005904:Glial Fibrillary Acidic Protein; D007608:Kainic Acid